Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-07-23

AUTHORS

Rohini K. Hernandez, David Quach, Sally W. Wade, Melissa Pirolli, Jane Quigley, Steven A. Narod, Alexander Liede

ABSTRACT

The purpose of this study was to estimate the prevalence of women receiving treatment or active surveillance for stage I–III breast cancer in the United States from 2009 to 2012, stratified by patient age and tumor characteristics. In each study year, electronic medical records were used to identify women aged ≥18 years with stage I–III breast cancer and treated or under active surveillance (≥4 visits) at an oncology clinic that contributes data to the Oncology Services Comprehensive Electronic Records database. Prevalence was projected to the national level overall and within strata (by tumor characteristics, year of breast cancer diagnosis, and age). We identified 5,219 female breast cancer patients (18 % More... »

PAGES

637-646

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10549-014-3052-1

DOI

http://dx.doi.org/10.1007/s10549-014-3052-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043026070

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25053278


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electronic Health Records", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Estrogen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Progesterone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triple Negative Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hernandez", 
        "givenName": "Rohini K.", 
        "id": "sg:person.0640327244.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640327244.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IMS Health, Plymouth Meeting, PA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IMS Health, Plymouth Meeting, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quach", 
        "givenName": "David", 
        "id": "sg:person.0706442444.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706442444.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wade Outcomes Research and Consulting, Salt Lake City, UT, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Wade Outcomes Research and Consulting, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wade", 
        "givenName": "Sally W.", 
        "id": "sg:person.0617012057.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IMS Health, Plymouth Meeting, PA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IMS Health, Plymouth Meeting, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pirolli", 
        "givenName": "Melissa", 
        "id": "sg:person.01022671044.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022671044.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IMS Health, Plymouth Meeting, PA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IMS Health, Plymouth Meeting, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quigley", 
        "givenName": "Jane", 
        "id": "sg:person.01136467072.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136467072.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Women\u2019s College Research Institute, 790 Bay Street, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.417199.3", 
          "name": [
            "Women\u2019s College Research Institute, 790 Bay Street, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Narod", 
        "givenName": "Steven A.", 
        "id": "sg:person.014417366562.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014417366562.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Observational Research, Amgen Inc., 1120 Veterans Blvd, ASF5, 94080, South San Francisco, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Center for Observational Research, Amgen Inc., 1120 Veterans Blvd, ASF5, 94080, South San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liede", 
        "givenName": "Alexander", 
        "id": "sg:person.01221004711.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221004711.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12672-010-0016-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045801854", 
          "https://doi.org/10.1007/s12672-010-0016-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-012-2329-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036175557", 
          "https://doi.org/10.1007/s10549-012-2329-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-011-2108-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011255060", 
          "https://doi.org/10.1245/s10434-011-2108-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-07-23", 
    "datePublishedReg": "2014-07-23", 
    "description": "Abstract The purpose of this study was to estimate the prevalence of women receiving treatment or active surveillance for stage I\u2013III breast cancer in the United States from 2009 to 2012, stratified by patient age and tumor characteristics. In each study year, electronic medical records were used to identify women aged \u226518\u00a0years with stage I\u2013III breast cancer and treated or under active surveillance (\u22654 visits) at an oncology clinic that contributes data to the Oncology Services Comprehensive Electronic Records database. Prevalence was projected to the national level overall and within strata (by tumor characteristics, year of breast cancer diagnosis, and age). We identified 5,219 female breast cancer patients (18\u00a0% 
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-014-3052-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-014-3052-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-014-3052-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-014-3052-1'


 

This table displays all metadata directly associated to this object as RDF triples.

248 TRIPLES      22 PREDICATES      115 URIs      104 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10549-014-3052-1 schema:about N18e0b3875e4f4a1ea549d6ca7da3ecdd
2 N2f346819428b4a1bbd4d3bf8f6f5bc73
3 N67bba7935d2b4489a1c3e85bdb536867
4 N76bc66d079ec486484e4b400b3bf5035
5 N7e849317168045e0aafd279cf6c447a3
6 N8e6d515ce7764fa0870850525498a6d7
7 N8ebb8cfd0b3c4ace9583c7347991991a
8 Na7812c8b4f2a4efabe0c1c51ccdd670a
9 Nca58b771fb4044958c362ce1d789aada
10 Ndc1f964868cd4eaa8baa37df33380978
11 Nde62616e080846aaa508f8d0c2da0901
12 Nff1fcbff2e744f1e8a1e8a33bd3d619c
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N3df34449b6514166b116153ddf1367f3
16 schema:citation sg:pub.10.1007/s10549-012-2329-5
17 sg:pub.10.1007/s12672-010-0016-8
18 sg:pub.10.1245/s10434-011-2108-2
19 schema:datePublished 2014-07-23
20 schema:datePublishedReg 2014-07-23
21 schema:description Abstract The purpose of this study was to estimate the prevalence of women receiving treatment or active surveillance for stage I–III breast cancer in the United States from 2009 to 2012, stratified by patient age and tumor characteristics. In each study year, electronic medical records were used to identify women aged ≥18 years with stage I–III breast cancer and treated or under active surveillance (≥4 visits) at an oncology clinic that contributes data to the Oncology Services Comprehensive Electronic Records database. Prevalence was projected to the national level overall and within strata (by tumor characteristics, year of breast cancer diagnosis, and age). We identified 5,219 female breast cancer patients (18 % <age 50; 58 % <age 65) representing 787,082 (95 % CI 778,012–796,153) women in the US in 2012. At diagnosis, 44 % had stage I, 42 % stage II, and 14 % stage III disease; 69 % had estrogen receptor (ER) and progesterone receptor (PR) expression-positive tumors; 19 % were ER- and PR-negative; and 14 % had triple-negative phenotype (ER-, PR-, and HER2-negative). Overall 56 % of patients received treatment in 2012, 22 % chemotherapy, 8 % biologic therapy, and 36 % endocrine therapy. Treatment prevalence was higher among younger patients and at more advanced disease stages. Approximately half of women with ER-negative, PR-positive, HER2-negative, or triple-negative tumors received chemotherapy. As a conclusion, in 2012, approximately 800,000 women in the US were under treatment or active surveillance for early-stage breast cancer. Treatment prevalence differed by patient age, disease stage, and tumor histology.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N43e83689e84f49759840487d345b6289
26 N9129416af62a4c25a2e524d70e9a3812
27 sg:journal.1092777
28 schema:keywords Abstract
29 Comprehensive Electronic Records database
30 HER2-negative
31 III disease
32 Oncology Services Comprehensive Electronic Records (OSCER) database
33 Services Comprehensive Electronic Records database
34 United States
35 active management
36 active surveillance
37 advanced disease stage
38 age
39 biologic therapy
40 breast cancer
41 breast cancer patients
42 cancer
43 cancer patients
44 characteristics
45 chemotherapy
46 clinic
47 conclusion
48 data
49 database
50 diagnosis
51 disease
52 disease stage
53 early-stage breast cancer
54 electronic health records
55 electronic medical records
56 electronic record database
57 endocrine therapy
58 estrogen receptor
59 expression-positive tumors
60 female breast cancer patients
61 half
62 half of women
63 health records
64 histology
65 levels
66 management
67 medical records
68 national level
69 oncology clinic
70 patient age
71 patients
72 phenotype
73 prevalence
74 prevalence of women
75 progesterone receptor (PR) expression-positive tumors
76 purpose
77 receptor (PR) expression-positive tumors
78 receptors
79 record database
80 records
81 stage
82 stage I
83 stage II
84 stage III disease
85 state
86 strata
87 study
88 study years
89 surveillance
90 therapy
91 treatment
92 treatment prevalence
93 triple-negative phenotype
94 triple-negative tumors
95 tumor characteristics
96 tumor histology
97 tumors
98 uses
99 women
100 years
101 younger patients
102 schema:name Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States
103 schema:pagination 637-646
104 schema:productId N5d4f9c1a91be4d44bf2ac46990ee0726
105 Na9209e4627c54cc082d3ca349517bfec
106 Ndb55cf6eccaa4b8385a9eb4fde7393fa
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043026070
108 https://doi.org/10.1007/s10549-014-3052-1
109 schema:sdDatePublished 2022-01-01T18:34
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher Nbab04400a6144f5cb2f428871fb3880b
112 schema:url https://doi.org/10.1007/s10549-014-3052-1
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N18e0b3875e4f4a1ea549d6ca7da3ecdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Receptors, Progesterone
118 rdf:type schema:DefinedTerm
119 N2f346819428b4a1bbd4d3bf8f6f5bc73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Aged
121 rdf:type schema:DefinedTerm
122 N3df34449b6514166b116153ddf1367f3 rdf:first sg:person.0640327244.86
123 rdf:rest Na615b4bbc48b45dc9317e5d61c8100df
124 N43e83689e84f49759840487d345b6289 schema:issueNumber 3
125 rdf:type schema:PublicationIssue
126 N5d4f9c1a91be4d44bf2ac46990ee0726 schema:name dimensions_id
127 schema:value pub.1043026070
128 rdf:type schema:PropertyValue
129 N65552a916433414cb650697b41283348 rdf:first sg:person.01022671044.26
130 rdf:rest Naa588fc1f85146ed89682686decbf722
131 N67bba7935d2b4489a1c3e85bdb536867 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Triple Negative Breast Neoplasms
133 rdf:type schema:DefinedTerm
134 N6bc2af809f854a0f9679b72c4d548872 rdf:first sg:person.01221004711.49
135 rdf:rest rdf:nil
136 N76bc66d079ec486484e4b400b3bf5035 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Adult
138 rdf:type schema:DefinedTerm
139 N7e849317168045e0aafd279cf6c447a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Middle Aged
141 rdf:type schema:DefinedTerm
142 N8e6d515ce7764fa0870850525498a6d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Humans
144 rdf:type schema:DefinedTerm
145 N8ebb8cfd0b3c4ace9583c7347991991a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Electronic Health Records
147 rdf:type schema:DefinedTerm
148 N9129416af62a4c25a2e524d70e9a3812 schema:volumeNumber 146
149 rdf:type schema:PublicationVolume
150 Na615b4bbc48b45dc9317e5d61c8100df rdf:first sg:person.0706442444.10
151 rdf:rest Nc71a29d02c084473a0351d8fc3ac9ceb
152 Na7812c8b4f2a4efabe0c1c51ccdd670a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name United States
154 rdf:type schema:DefinedTerm
155 Na9209e4627c54cc082d3ca349517bfec schema:name pubmed_id
156 schema:value 25053278
157 rdf:type schema:PropertyValue
158 Naa588fc1f85146ed89682686decbf722 rdf:first sg:person.01136467072.89
159 rdf:rest Naba197d903a6404f8d38071c391fa542
160 Naba197d903a6404f8d38071c391fa542 rdf:first sg:person.014417366562.02
161 rdf:rest N6bc2af809f854a0f9679b72c4d548872
162 Nbab04400a6144f5cb2f428871fb3880b schema:name Springer Nature - SN SciGraph project
163 rdf:type schema:Organization
164 Nc71a29d02c084473a0351d8fc3ac9ceb rdf:first sg:person.0617012057.00
165 rdf:rest N65552a916433414cb650697b41283348
166 Nca58b771fb4044958c362ce1d789aada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Neoplasm Staging
168 rdf:type schema:DefinedTerm
169 Ndb55cf6eccaa4b8385a9eb4fde7393fa schema:name doi
170 schema:value 10.1007/s10549-014-3052-1
171 rdf:type schema:PropertyValue
172 Ndc1f964868cd4eaa8baa37df33380978 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Receptor, ErbB-2
174 rdf:type schema:DefinedTerm
175 Nde62616e080846aaa508f8d0c2da0901 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Female
177 rdf:type schema:DefinedTerm
178 Nff1fcbff2e744f1e8a1e8a33bd3d619c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Receptors, Estrogen
180 rdf:type schema:DefinedTerm
181 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical and Health Sciences
183 rdf:type schema:DefinedTerm
184 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
185 schema:name Oncology and Carcinogenesis
186 rdf:type schema:DefinedTerm
187 sg:journal.1092777 schema:issn 0167-6806
188 1573-7217
189 schema:name Breast Cancer Research and Treatment
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.01022671044.26 schema:affiliation grid-institutes:None
193 schema:familyName Pirolli
194 schema:givenName Melissa
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022671044.26
196 rdf:type schema:Person
197 sg:person.01136467072.89 schema:affiliation grid-institutes:None
198 schema:familyName Quigley
199 schema:givenName Jane
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136467072.89
201 rdf:type schema:Person
202 sg:person.01221004711.49 schema:affiliation grid-institutes:grid.417886.4
203 schema:familyName Liede
204 schema:givenName Alexander
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221004711.49
206 rdf:type schema:Person
207 sg:person.014417366562.02 schema:affiliation grid-institutes:grid.417199.3
208 schema:familyName Narod
209 schema:givenName Steven A.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014417366562.02
211 rdf:type schema:Person
212 sg:person.0617012057.00 schema:affiliation grid-institutes:None
213 schema:familyName Wade
214 schema:givenName Sally W.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617012057.00
216 rdf:type schema:Person
217 sg:person.0640327244.86 schema:affiliation grid-institutes:grid.417886.4
218 schema:familyName Hernandez
219 schema:givenName Rohini K.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640327244.86
221 rdf:type schema:Person
222 sg:person.0706442444.10 schema:affiliation grid-institutes:None
223 schema:familyName Quach
224 schema:givenName David
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706442444.10
226 rdf:type schema:Person
227 sg:pub.10.1007/s10549-012-2329-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036175557
228 https://doi.org/10.1007/s10549-012-2329-5
229 rdf:type schema:CreativeWork
230 sg:pub.10.1007/s12672-010-0016-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045801854
231 https://doi.org/10.1007/s12672-010-0016-8
232 rdf:type schema:CreativeWork
233 sg:pub.10.1245/s10434-011-2108-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011255060
234 https://doi.org/10.1245/s10434-011-2108-2
235 rdf:type schema:CreativeWork
236 grid-institutes:None schema:alternateName IMS Health, Plymouth Meeting, PA, USA
237 Wade Outcomes Research and Consulting, Salt Lake City, UT, USA
238 schema:name IMS Health, Plymouth Meeting, PA, USA
239 Wade Outcomes Research and Consulting, Salt Lake City, UT, USA
240 rdf:type schema:Organization
241 grid-institutes:grid.417199.3 schema:alternateName Women’s College Research Institute, 790 Bay Street, Toronto, ON, Canada
242 schema:name Women’s College Research Institute, 790 Bay Street, Toronto, ON, Canada
243 rdf:type schema:Organization
244 grid-institutes:grid.417886.4 schema:alternateName Center for Observational Research, Amgen Inc., 1120 Veterans Blvd, ASF5, 94080, South San Francisco, CA, USA
245 Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA
246 schema:name Center for Observational Research, Amgen Inc., 1120 Veterans Blvd, ASF5, 94080, South San Francisco, CA, USA
247 Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA
248 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...